Researchers from North Carolina State University have engineered designer biosensors that can detect antibiotic molecules of interest. The biosensors are a first step toward creating antibiotic-producing “factories” within microbes such as E. coli.
Macrolides are a group of naturally occurring small molecules that can have antibiotic, antifungal or anticancer effects. The antibiotic erythromycin is one example – it is a macrolide produced by soil-dwelling bacteria. Researchers are interested in using these natural antibiotics and the microbes that produce them in order to develop new antibiotics; however, microbes that produce antibiotic macrolides only make small amounts of a limited variety of antibiotics.
“Our ultimate goal is to engineer microbes to make new versions of these antibiotics for our use, which will drastically reduce the amount of time and money necessary for new drug testing and development,” says Gavin Williams, associate professor of bio-organic chemistry at NC State and corresponding author of a paper describing the research. “In order to do that, we first need to be able to detect the antibiotic molecules of interest produced by the microbes.”
Williams and his team used a naturally occurring molecular switch – a protein called MphR – as their biosensor. In E. coli, MphR can detect the presence of macrolide antibiotics being secreted by microbes that are attacking E. coli. When MphR senses the antibiotic, it turns on a resistance mechanism to negate the antibiotic’s effects.
The researchers created a large library of MphR protein variants and screened them for the ability to switch on production of a fluorescent green protein when they were in the presence of a desired macrolide. They tested the variants against erythromycin, which MphR already recognizes, and found that some of the MphR variants improved their detection ability tenfold. They also successfully tested the variants against macrolides that were not closely related to erythromycin, such as tylosin.
“Essentially we have co-opted and evolved the MphR sensor system, increasing its sensitivity in recognizing the molecules that we’re interested in,” says Williams. “We know that we can tailor this biosensor and that it will detect the molecules we’re interested in, which will enable us to screen millions of different strains quickly. This is the first step toward high-throughput engineering of antibiotics, where we create vast libraries of genetically modified strains and variants of microbes in order to find the few strains and variants that produce the desired molecule in the desired yield.”
The Latest on: Antibiotics
- Animal Antibiotics And Antimicrobials Market 2020 Capacity Utilization Rate, Ex-Factory Price, Revenue and Gross Margin Analysis to 2026on May 10, 2020 at 1:15 am
Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Animal Antibiotics And Antimicrobials Market” report provides valuable information regarding new products in the ...
- New mums with non-routine births to be given antibiotics for first timeon May 9, 2020 at 8:30 pm
Thousands of new mums will be spared pain and long-term health problems after NHS guidelines were changed. Women who experience non-routine births will now be given routine antibiotics for the first ...
- Staying hygienic cuts down the use of antibiotics: studyon May 9, 2020 at 5:11 pm
Washington DC [USA], May 9 (ANI): Improving hygiene practices like washing hands reduces the risk of catching infections by 50 percent and cuts the use of antibiotics by 30 percent, suggests a new ...
- Hygiene reduces the need for antibiotics by up to 30%on May 8, 2020 at 12:19 am
According to a new Position Paper published in the American Journal of Infection Control (AJIC) online, improved everyday hygiene practices, such as hand-washing, reduces the risk of common infections ...
- Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class ; Action Mechanism, and Geographyon May 7, 2020 at 2:52 pm
The antibiotics was valued at US$ 43,348.38 million in 2019 and is projected to reach US$ 56,351.33 million by 2027; it is expected to grow ...
- Why bacteria's resistance to antibiotics is a problem in a viral pandemicon May 6, 2020 at 9:28 am
Each year a particular kind of infection kills more than 35,000 people in the United States. Those deaths are caused by antibiotic-resistant bacteria.
- UKZN professor warns against use of antibiotics to treat Covid-19 patientson May 6, 2020 at 3:28 am
Durban - South African Research Chair in Antibiotic Resistance, Professor Sabiha Essack is calling on healthcare providers to exercise prudence when prescribing antibiotics to Covid-19 patients.
- Antibiotics Market 2020 Size, Share, Growth, Demand, Application, Types, Top Key Players and Current Business Trends by 2026on May 6, 2020 at 1:04 am
Advanced report on ' Antibiotics market' Added by Analytical Research Cognizance, offers details on current and future growth ...
- Watchdog: HHS Failed To Properly Incentivize Development Of Antibiotics In Era Of Superbugson May 5, 2020 at 8:45 pm
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
- Dr. Cornelius Clancy: To combat coronavirus, we may need more antibioticson May 5, 2020 at 11:00 am
Cornelius Clancy, M.D., is an associate professor of medicine and director of the XDR Pathogen Lab at the University of Pittsburgh. The coronavirus infects and kills more Americans each day. The ...
via Google News and Bing News